Anna Goodman, consultant in infectious diseases and general medicine
Tel: 020 7188 3148
Areas of expertise: COVID-19 vaccines, clinical trials in infection, community-acquired bacterial infections, malaria, S. aureus bacteraemia, Candida, imaging in infection
Anna Goodman is a consultant in infectious diseases and general (internal) medicine. She has been a consultant at Guy's and St Thomas' since 2014 and also works at the MRC clinical trials unit at UCL as an associate professor. Anna runs a general infectious diseases clinic on Thursday afternoons. She also supports a dermatology/infectious diseases specialist clinic.
Anna specialises in clinical trials in infectious diseases. She has been the local principal investigator for a number of vaccine trials in malaria and more recently COVID-19.
Anna trained in medicine at Oxford University and the University of London.
Education and training
- MRCP (infectious diseases)
- MA (Oxon)
- MBBS (Oxford University and University College London)
Key recent publications
Treatment of methicillin-resistant Staphylcoccus aureus (MRSA): updated guidelines from the UK J Antimicrobial Chemo in press
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK Voysey et al. Lancet 8th Dec 2020
Remdesivir for the Treatment of Covid-19 — N Engl J Med 2020; 383:1813-1826
Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet. 2018 391(10121):668-678